Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-06

Clinical Trial Update: A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing enzalutamide in prostate cancer patients who have never received hormone therapy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-04-06